VaccinesArchives
Meningococcal vaccination disparities in the United States (2010–2021): Findings from the National Immunization Survey-Teen and a commercial insurance database
Vaccines 1 min.
In the United States, while meningococcal vaccines are available and recommended for adolescents and young adults, coverage remains low and disparities persist. We evaluated meningococcal serogroups A, C, W, Y (MenACWY) and B (MenB) vaccine uptake, completion, and compliance using a cross-sectional analysis...
PLGA/PVA nanoparticles to deliver a protein-based cancer vaccine targeting GPC1 for the treatment of pancreatic ductal adenocarcinoma
Vaccines 1 min.
Therapeutic cancer vaccines have been proposed to stimulate an immune response for controlling disease progression and reducing treatment recurrence in cancer, such as pancreatic ductal adenocarcinoma (PDAC). Here, we proposed the use of PLGA/PVA nanoparticles (NPs) as the delivery component of a vaccine...
Acquired Haemophilia A and COVID-19 mRNA Vaccine Tozinameran: Analysis of Cases Registered in the French PharmacoVigilance Database.
Vaccines 1 min.
Acquired haemophilia A (AHA) is a rare autoimmune bleeding disorder commonly associated with autoimmune disorders, malignancies, infections, pregnancy, and certain medications. During the COVID-19 vaccination campaign, several case reports have documented instances of AHA occurring subsequent to SARS-CoV-2...
The role of chitosan-based nano systems in emerging vaccine technologies: current status and future expectations
Vaccines 1 min.
The multifunctional potential of chitosan, which is a natural biopolymer derived from chitin, in the field of vaccine formulation will be explored in this review. Firstly, how this unique chemically versatile structure of chitosan allows scientists to tailor nano systems that precisely control the delivery...
